KislingerThomas Profile Banner
Thomas Kislinger Profile
Thomas Kislinger

@KislingerThomas

Followers
1K
Following
17K
Media
133
Statuses
765

Clinical Proteomics, Cancer Biology & Mass Spectrometry @MBPatUofT and @pmcancercentre 🇨🇦

Toronto, Ontario
Joined March 2019
Don't wanna be here? Send us removal request.
@KislingerThomas
Thomas Kislinger
22 days
checkout our latest paper in @NatureBiotech. We developed a graph-based algorithm that comprehensively generates non-canonical peptides in linear time.
1
12
52
@KislingerThomas
Thomas Kislinger
7 days
Phenotypic screens for SIRPA expression reveal RAB21 as a general regulator of macrophage surface identity: Cell Reports
0
0
3
@KislingerThomas
Thomas Kislinger
8 days
RT @CellReports: Phenotypic screens for SIRPA expression reveal RAB21 as a general regulator of macrophage surface identity .
0
5
0
@KislingerThomas
Thomas Kislinger
12 days
RT @Chenghao_Zhu: Just came across a fantastic article covering our work on moPepGen — truly honored by the thoughtful writing and high pra….
0
1
0
@KislingerThomas
Thomas Kislinger
21 days
Identification of non-canonical peptides with moPepGen
0
0
5
@KislingerThomas
Thomas Kislinger
22 days
RT @Chenghao_Zhu: Our paper on moPepGen is finally out in Nature Biotechnology!.moPepGen is a fast graph-based tool for systematically pred….
0
4
0
@KislingerThomas
Thomas Kislinger
22 days
RT @PMResearch_UHN: A new tool, moPepGen, developed by @uhn @pmcancercentre & @UCLAHealth, can predict & detect unusual proteins involved i….
0
1
0
@KislingerThomas
Thomas Kislinger
22 days
Great collaborations with our colleagues @UCLA @TheBoutrosLab and led by outstanding trainees @Chenghao_Zhu @AnnieHahkl and Lydia Liu.
0
0
2
@KislingerThomas
Thomas Kislinger
22 days
RT @NatureBiotech: Identification of non-canonical peptides with moPepGen
Tweet media one
0
31
0
@KislingerThomas
Thomas Kislinger
1 month
RT @Schwartastic: We are proud to announce the publication of CellNEST, deep-learning detection single cell-cell or even "relay" communicat….
0
5
0
@KislingerThomas
Thomas Kislinger
2 months
RT @giuliosf: Paper(s) alert from our @RESOLUTE_IMI project – In a compilation of four papers in Molecular Systems Biology we show how we w….
0
5
0
@KislingerThomas
Thomas Kislinger
2 months
RT @DrAMansouri: .CNS lymphoma is a challenging disease to manage. Intraventricular chemotherapy may hold promise,….
0
4
0
@KislingerThomas
Thomas Kislinger
2 months
New collaborative work from PhD student Aastha. Using proteomics for CSF-based biomarker discovery @DrAMansouri . Cerebrospinal fluid protein biomarkers are associated with response to multiagent intraventricular chemotherapy in …
0
0
8
@KislingerThomas
Thomas Kislinger
3 months
New review from our team. Recent implementations of data-independent acquisition for cancer biomarker discovery in biological fluids
0
1
7
@KislingerThomas
Thomas Kislinger
4 months
RT @CRC_AACR: Today at #AACRprecmed25, Thomas Kislinger will speak in Plenary Session 6: New Omics for Precision Medicine. Read his work in….
0
1
0
@KislingerThomas
Thomas Kislinger
4 months
RT @AACR: Bernhard Küster, Thomas Kislinger, and M. Celeste Simon discussed "New Omics for Precision Medicine" in a plenary session at the….
0
4
0
@KislingerThomas
Thomas Kislinger
4 months
New collaborative work on CSF proteomics with @DrAMansouri . Great work by PhD student Aastha and team.
0
2
6
@KislingerThomas
Thomas Kislinger
4 months
CSF protein biomarkers are associated with response to multi-agent intraventricular chemotherapy in patients with CNS lymphoma
1
4
7
@KislingerThomas
Thomas Kislinger
5 months
RT @DrAMansouri: For aggressive brain tumors (gliomas and brain metastases), there is a pressing need for more real time evaluation of drug….
0
12
0